New melanoma drugs — why do so few benefit?

(Editor: Melanoma is the #1 cancer in young adults, accounting for 25% of all cases in the US annually. Let's think a little bit before we blindly give our hard earned money to the billion dollar cancer society thinking we're going to help young adults with melanoma. Hint: You're not.)



When they work, new melanoma treatments that enlist the help of the immune system to attack tumors can have a stunning effect, in some cases arresting the deadly skin cancer for four years. But typically just a handful of patients get that kind of response.



read more|digg story